Pharmacists in Clinton, Massachusetts


15 Pharmacists found in Clinton
female pharmacist

Aislinn Soofi


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

female pharmacist

Anne Marie Kilcoyne


Pharmacist
792 Main St, Clinton, MA 01510
978-368-7631    

male pharmacist

Jacob Hunt, PHARMD


Pharmacist
720 Main St, Clinton, MA 01510
978-368-3484    



female pharmacist

Dr. Julie Ngo


Pharmacist
792 Main St, Clinton, MA 01510
978-368-7631    

male pharmacist

Long Kim Tran


Pharmacist
792 Main St, Clinton, MA 01510
978-368-7631    

female pharmacist

Ms. Lu Jin


Pharmacist
720 Main St, Clinton, MA 01510
978-368-3484     978-368-9029

female pharmacist

Mami Shindo


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

male pharmacist

Dr. Mark Gordon Richardson


Pharmacist
720 Main St, Clinton, MA 01510
978-368-3484    

female pharmacist

Marylyn Ha-trinh



792 Main St, Clinton, MA 01510
978-368-7631     978-365-5491

male pharmacist

Michael Arthur Gillis, PHARMD


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

male pharmacist

Nicholas Lucier, PHARMD.


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

male pharmacist

Robert Francis Riley, PHARMD


Pharmacist
720 Main St, Clinton, MA 01510
978-368-3484    

male pharmacist

Dr. Roy Albert Courchaine Jr., PHARMD.


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

male pharmacist

Scott Thomas Kiely, PHARMD, RPH


Pharmacist
1031 Main St, Clinton, MA 01510
978-368-8540    

male pharmacist

Thomas Hoang, RPH,CDM,LIC.AC,M.AC,



1031 Main St, Clinton, MA 01510
978-368-8540    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.